CLINICAL_TRIALS
trial_result
· 2009-08-13
Clinical Trial Update: Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH [Phase 1]
Summary
Pfizer’s Phase 1 pharmacokinetic study of CP-945598 in patients with Non-Alcoholic Steatohepatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Non-Alcoholic Steatohepatitis(NASH) | Phase 1 | Status: COMPLETED